| |

Living With Mesothelioma: Coping Strategies to Find Hope

Living With Mesothelioma: Coping Strategies to Find Hope

Mesothelioma is a cancer caused by exposure to asbestos. One key question remains unanswered. How do diagnosed patients experience living with mesothelioma?

A new study in Health Psychology aimed to explore the mesothelioma patient experience.

Data from 22 different research studies were analyzed. The coping strategies highlighted here provide hope for mesothelioma patients and caregivers. The results bring awareness of the patient experience, coping processes, and support pathways.

Two Coping Strategies to Support a Mesothelioma Patient

The best coping strategies help patients reclaim a sense of mental calm, individual autonomy, and meaning. These strategies can also reduce the trauma of living with mesothelioma.

Patients who accepted the diagnosis fully were more optimistic than those in denial. Patients who accepted the diagnosis were able to reorient their perspectives. They were able to retrain their thinking away from negative thoughts. These patients were also able to find good in the opportunities still ahead of them. This approach gave them something to aspire to during the hardship of disease.

Others framed mesothelioma and their cancer journeys as a war. They positioned mesothelioma as an enemy that can be defeated using stoic resolve and effort. These patients reframed the diagnosis as a challenge to overcome.

Both of these strategies appeared to help patients reclaim a sense of control. These approaches helped them to adopt a more active role in their clinical journeys. This helped ease feelings of anxiety while living with mesothelioma.

External Sources of Support for Mesothelioma Patients

Many mesothelioma patients also relied heavily on external support. Family-based support can enhance a patient’s emotional coping. Often a family can help to ease the build-up of negative emotions.

Another kind of support comes from fellow mesothelioma patients. This peer support can help because it lets mesothelioma share their experiences, hoped and fears. Patients can also be honest in sharing the practical challenges of the disease.

Information-based support from reliable on-line sources such as SurvivingMesothelioma.com were also valued.  These resources avoided complex medical terms and provided meaningful news and information on mesothelioma, . Resources such as these were highly valued by patients and allowed for greater patient empowerment.

How to Practice Coping Strategies for Mesothelioma Patients

Clinicians, patients, and caregivers can integrate these strategies to help mesothelioma patients. They can increase a patient’s acceptance, hope, and empowerment.

One coping method is to accept the mesothelioma diagnosis and all that it entails. Thereby promoting a positive outlook on life. Another coping method is to position mesothelioma as an enemy that can be defeated.

External sources of support for mesothelioma patients are equally important. Family and peer-based support provide structure and community for the patient.

Wherever possible, patient support should seek to empower patient autonomy and encourage positivity. These strategies can help a patient living with mesothelioma. They can help patients reclaim a sense of purpose. The key is to tailor support where possible to better meet a patient’s needs and preferences.

Source

Lond, Benjamin, Kerry Quincey, Lindsay Apps, Liz Darlison, and Iain Williamson. “The experience of living with mesothelioma: A meta-ethnographic review and synthesis of the qualitative literature.” Health Psychology (2022). https://psycnet.apa.org/doi/10.1037/hea0001166

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…